In the present study, hAFSCs treatment after cerebral stroke in T1DM rats significantly reduced the expression of pro‐inflammatory factor (MMP9) and ED‐1 (marker of macrophage) in ischaemic brain. The gene discussed is EDA; the disease is type 1 diabetes mellitus.